Kilbas, ImdatKahraman Kilbas, Elmas PinarHorhat, Florin GeorgeCiftci, Ihsan Hakki2025-09-102025-09-1020252309-608X10.3390/jof110806032-s2.0-105014405913https://doi.org/10.3390/jof11080603https://hdl.handle.net/20.500.14627/1159This study aimed to systematically evaluate the resistance rates of Candida albicans to various antifungals based on studies conducted in Turkiye and published between 2005 and 2025 and to analyze the factors contributing to resistance. A systematic literature search was conducted using various keywords in electronic databases (PubMed, Embase, Web of Science, EBSCO, Scopus, Turk Medline and Google Scholar). A total of 42 studies were included in the meta-analysis according to the determined criteria. The quality of the studies was assessed using the Joanna Briggs Institute checklist, and the analyses were performed using appropriate statistical software. The highest resistance rates for fluconazole, itraconazole, and voriconazole were observed in the Aegean and Marmara regions. In the analyses performed with the random-effects model, heterogeneity was found to be high for itraconazole, fluconazole, posaconazole, voriconazole, and caspofungin, and the strongest explanatory variable of this heterogeneity was the geographical region variable. In our study, we determined that antifungal resistance in C. albicans strains in Turkiye is generally low; however, an increasing trend has been observed over the years, especially in amphotericin B resistance. Although the low resistance rates to major antifungal agents such as fluconazole, voriconazole and echinocandins are promising, regional differences and methodological heterogeneity necessitate the development of treatment strategies based on local data.eninfo:eu-repo/semantics/openAccessCandida AlbicansAntifungal ResistanceSystematic ReviewMeta-AnalysisTurkiyeArticleQ1Q2118WOS:001557821300001